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TO THE EDITOR
Current military campaigns in Iraq and
Afghanistan have seen the deployment
of over three million soldiers to equa-
torial latitudes (www.va.gov/vetdata/
Veteran_Population.asp and www.
defense.gov/, accessed on 20 Septem-
ber 2014). The rate of unprotected sun
exposure in these theaters is a signiﬁ-
cant concern, especially as 80% of the
veterans are of Caucasian ethnicity
(www.va.gov/vetdata/Veteran_Population.
asp, accessed on 25 September 2011;
Woolley and Hughes, 2013; Armed
Forces Health Surveillance C, 2014;
Lea et al., 2014). Careful examination of
melanoma mortality data among veterans
suggests that soldiers have been exposed
to high doses of intermittent UV light
while deployed, which may explain
frequent observations of increased risk of
skin cancer in former servicemen (Brown
et al., 1984; Garland et al., 1990; Ramani
and Bennett, 1993; Page et al., 2000;
Yamane, 2006; Linos et al., 2009; Rogers
et al., 2010; Strand et al., 2011; Zhou
et al., 2011; Lea et al., 2014).
We hypothesized that United States
military workers had excessive expo-
sure to UVR—during recent missions to
Iraq and Afghanistan. We conducted an
anonymous survey of veterans returning
from Operation Enduring Freedom
(OEF)/Operation Iraqi Freedom (OIF)/
Operation New Dawn (OND) missions
and presenting for care at the Tennessee
Valley Healthcare System (TVHS) in
Nashville, TN, to assess practices during
deployment. Surveys (n= 212) were
analyzed from the Post-Deployment
Clinic at the Nashville TVHS. Demo-
graphics (Table 1) reﬂected the
population of the clinic with over 80%
having Army branch representation,
over 80% having returned more than
12 months prior, and almost 97% male.
Eighty-four percent of respondents
reported deployment in a desert cli-
mate, 77% spent 4 or more hours
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Table 1. SPUS and sunburn by predictive factors
No. of subjects
(%)
Mean
SPUS± SD1
Subjects
sunburned (%) χ2 (sunburns)2
Age
18–25 (a) 27 (12.7) 4.37± 1.04d 18 (66.7)
26–30 (b) 65 (30.7) 4.58± 1.65d 37 (56.9)
31–35 (c) 43 (20.3) 4.93± 1.62 25 (58.1)
435 (d) 77 (36.3) 5.18± 1.56a,b 54 (70.1)
Race
Caucasian non-Hispanic (a) 138 (65.1) 5.00± 1.60 99 (71.7) c
Caucasian Hispanic 15 (7.1) 4.60± 1.35 10 (66.7)
African-American (c) 42 (19.8) 4.57± 1.52 16 (38.1) a
Fitzpatrick skin type
Types I or II (a) 38 (17.9) 5.00± 1.64 31 (81.6) c, d
Type III (b) 64 (30.2) 5.09± 1.53 51 (79.7) c, d
Type IV (c) 52 (24.5) 4.62± 1.48 32 (61.5) a, b, d
Type V or VI (d) 54 (25.5) 4.78± 1.54 19 (35.2) a, b, d
Primary duties
Work outdoors requiring physical
exertion (a)
156 (73.6) 4.72± 1.61b 106 (67.9) b
All others (b) 56 (26.4) 5.18± 1.40a 28 (50.0) a
Hours working in bright sun per day
0–3Hours (a) 48 (22.6) 5.19± 1.76c 18 (37.5) b, c
4–6Hours (b) 53 (25.0) 5.11± 1.44c 34 (64.1) a
46Hours (c) 111 (52.4) 4.57± 1.50a,b 82 (73.9) a
SPAS3
0–4 Points (a) 53 (25.0) 3.68± 1.31b 33 (62.3)
5–8 Points (b) 159 (75.0) 5.23± 1.45a 101 (63.5)
Abbreviations: SPAS, Sun Protection Availability Score; SPUS, Sun Protection Use Score.
1Superscript indicates test of differences in the scores between categories of each factor in row order.
Letters indicate signiﬁcant differences at Po0.05 in comparison with other categories; boldface of the
letters indicates Po0.01.
2Letters indicate signiﬁcant differences at Po0.05 in comparison with other categories; boldface of the
letters indicates Po0.01.
Accepted article preview online 25 June 2015; published online 16 July 2015
Abbreviations: OEF, Operation Enduring Freedom; OIF, Operation Iraqi Freedom; OND, Operation
New Dawn; SPAS, Sun Protection Availability Score; SPF, sun protection factor; SPUS, Sun Protection
Use Score; TVHS, Tennessee Valley Healthcare System; VA, Veterans Affair
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per day working in the bright sun, and
64% reported more than three-quarter
days in bright sun.
Sunscreen use was reported as spora-
dic (59%), sometimes (28%), and routine
(13%). Fewer than 30% reported having
routine access to sunscreen while work-
ing. Most respondents reported that the
face, neck, and arms/hands were unpro-
tected 70% of the time or more. Usage of
various forms of sun protection while
working (sunscreen, shade structures,
hat/headgear, sunglasses) was measured
via a Sun Protection Use Score (SPUS)
with a range of 0 to 8 (mean score, 4.84
(±1.57) and was low in all subgroups
(Table 1).
A higher Sun Protection Availability
Score (SPAS) measuring the availability
of sunscreen, shade structures, hats,
and sunglasses correlated with greater
use of sun protection (r (210)= 0.59,
Po0.0001; Table 2). Multivariate regres-
sion revealed an association between
SPUS with older age (P=0.03), fewer
months (o12) since return (P=0.04), arid
climate (P=0.003), and higher SPAS
(Po0.0001). Those working 46 hours
per day in the sun had signiﬁcantly lower
SPAS (Po0.01).
Sixty-three percent of respondents had
at least one sunburn during deployment,
primarily on the face (58%), neck (59%),
and arms/hands (35%). Overall, 43% had
2+ sunburns, and 20% reported blistering
sunburns. Of those working 46 hours in
bright sun, 74% were sunburned. Twenty-
ﬁve percent of respondents working 46
hours in the sun reported blistering
sunburns compared with less-exposed
individuals (vs. 14%, P=0.047). Multi-
variable regression analysis showed that
Fitzpatrick skin type (Po0.001), military
branch (P=0.02), and hours working in
bright sun per day (Po0.001) were
associated with sunburns. SPAS and
sunburns were negatively correlated, r
(210)=−0.17, Po0.05.
Only 23% of veterans reported that
they were made very aware of the risks of
skin cancer by the US military. Overall,
29% of respondents noticed a changing
mole after their mission. Only 13% of
veterans correctly identiﬁed the back as
the most common site for melanoma
in men (Table 2).
Herein, many respondents had experi-
ences increasing their risk for skin
cancer. They report signiﬁcant sun expo-
sure but only limited access to sunscreen
despite their face, neck, and arms being
routinely exposed to the bright sun. The
combination of high intensity sun expo-
sure, fair skin, less than optimal access,
and low utilization was associated with
63% of respondents experiencing sun-
burn and 20% reporting a blistering
sunburn.
Paradoxically, the groups with the
highest occupational risk for skin cancer
had the lowest utilization of sun protec-
tion. As working46 hours in the sun was
associated with lower SPAS (Po0.01),
access to sun protection may be an
underlying issue to be improved as it
has been shown in other high-exposure
populations that easy access improves
utilization (Dubas and Adams, 2012).
Study limitations are size of the
sample, its regional nature, and its
limitation to primarily one military
branch. In addition, 80% of responses
relied on recall of 41 year.
Future studies should expand to more
national samples representing other mili-
tary branches and seek greater detail on
the reasons for under-utilization of sun
protection and methods that are practi-
cal in the combat theater. Melanoma
education and screening are important
goals in this high-risk low-awareness
population.
This study was conducted with the
approval of the VA TVHS institutional
review board and compliant with the
Declaration of Helsinki Principles. Eli-
gible research subjects included all
OEF/OIF/OND veterans, 18 years and
older, receiving primary care within the
Nashville VA TVHS from December
2013 to May 2014. All veterans attend-
ing clinic were invited via anonymous,
optional paper surveys, administered at
check-in (implied consent), and depos-
ited in a locked box.
The survey tool, developed with
OEF/OIF/OND veteran input, consisted
of 30 multiple choice questions
addressing the latest deployment
only. These included key elements of
demographics, military service sun
exposure, sun protection availability,
sun protection utilization, and skin
cancer prevention knowledge.
Study data were collected and man-
aged using REDCap (Research Electro-
nic Data Capture) electronic data
capture tools hosted at Vanderbilt Uni-
versity (Harris et al., 2009).
Table 2. Sun protection and skin cancer awareness
Never/rarely (%) Somewhat (%) Always (%)
Availability of sun protection
Sunscreen 70 (33.0) 82 (38.7) 60 (28.3)
Sunglasses 12 (5.7) 25 (11.8) 175 (82.6
Hats/headgear 17 (8.0) 14 (6.6) 181 (85.4)
Shade structures 51 (24.1) 109 (51.4) 52 (24.5
Body sites routinely unprotected
Face 180 (84.9)
Scalp 60 (28.3)
Neck 159 (75.0)
Arms/hands 150 (70.8)
Legs 11 (5.2)
Shoulders/back 9 (4.3)
Stomach/chest 5 (2.4)
Mole changes since deployment
Subjects 61 (29)
Made aware of risk of skin cancer by military Not at All Somewhat Very
Subjects 88 (41.7%) 74 (35.1%) 49 (23.2%)
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To analyze usage and availability of
sun protection devices, sun protection
scores (SPUS and SPAS) were created.
Points were given for subjects’
responses regarding usage of sunscreen,
sunglasses, hats/headgear, or shade
structures. Sporadic use received 0
points, occasional use received 1 point,
and routine use received 2 points.
For statistical analysis, independent
sample t-tests assuming unequal var-
iance and χ2 tests were used for group
comparisons when appropriate. Pear-
son’s correlation coefﬁcient (r) was used
for correlation analyses. A multivariate
linear/logistic regression model was
designed and performed for sun protec-
tion use and for sunburns. Two-tailed
P-valueso0.05 were considered to
be statistically signiﬁcant. Statistical
analyses were carried out using
Stata Statistical Software, version 12
(Statacorp, College Station, TX).
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TO THE EDITOR
Transforming growth factor-β (TGF-β)
and platelet-derived growth factor (PDGF)
are central mediators of ﬁbrosis, and
their overexpression contributes to
the pathophysiology of scleroderma,
chieﬂy by inducing the overproduction
of extracellular matrix proteins (ECM)
by dermal ﬁbroblasts (Gay et al., 1989;
Sargent et al., 2010; Bhattacharyya
et al., 2012). TGF-β also promotes the
differentiation of dermal ﬁbroblasts into
myoﬁbroblasts, which are key mediators
of scleroderma (Abraham et al., 2007).
Thus, targeting this pathway is a
reasonable strategy to treat a variety of
ﬁbrotic diseases including scleroderma,
for which current treatment options are
limited. Herein we explore the potential
of novel mTOR inhibition as a means to
block the pro-ﬁbrotic effects of TGF-β.
Recent studies have suggested a func-
tional role of mTOR in ﬁbrotic diseasesAccepted article preview online 2 July 2015; published online 6 August 2015
Abbreviations: ECM, Extracellular matrix; MTT, (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium
Bromide); NHDF, Normal human dermal ﬁbroblasts; PDGF, Platelet derived growth factor; TGF-β,
Transforming growth factor-β
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